Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Ekterly (sebetralstat) the First and Only Oral On-demand Treatment for Hereditary Angioedema (HAE)
CAMBRIDGE, Mass. & SALISBURY, England, July 7, 2025 (BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food...
FDA Grants Accelerated Approval to Lynozyfic (linvoseltamab-gcpt) for Treatment of Relapsed or Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic...
FDA Grants Accelerated Approval to Zegfrovy (sunvozertinib) for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
July 2, 2025 – Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological...
Inflammatory Activity With IBD Tied to Impaired Sleep
Impaired sleep is associated with inflammatory activity in inflammatory bowel disease (IBD), but not symptoms, according to a study published online June...
Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers
Sleep disorders such as obstructive sleep apnea (OSA) contribute to mental health challenges, traumatic injuries, and increased health care utilization...
Increase in Chronic Digestive Disorders Seen During Pandemic
There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a study...
Adolescent Vaping of THC, Cannabidiol, Synthetic Cannabinoids Increasing
Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023, according to a study...
Barbie's Latest Look? It Includes an Insulin Pump and Glucose Monitor
WEDNESDAY, July 9, 2025 — Barbie’s latest look includes a polka-dot crop top, chunky heels — and an insulin pump. Mattel has released...
First Malaria Drug Approved for Newborns and Small Babies, Coartem Baby
WEDNESDAY, July 9, 2025 — A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care for some...
RFK Jr. Praises Meal Program Critics Say Is Ultra-Processed
WEDNESDAY, July 9, 2025 — A government-backed meal delivery service for people on Medicaid and Medicare is getting national attention — but...
AI Displays Racial Bias Evaluating Mental Health Cases
WEDNESDAY, July 9, 2025 — AI programs can exhibit racial bias when evaluating patients for mental health problems, a new study says. Psychiatric...
Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis
Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for differentiated...
Is One Type of Water Healthier Than Another? Here’s What Experts Say
SUNDAY, July 6, 2025 — Alkaline. Electrolyte. Flavored. Walk down the beverage aisle and you’ll find all kinds of waters promising extra health...
Recently Added
Recently added consumer and prescribing information: Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Ekterly Ekterly (sebetralstat) is an oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema attacks in adults and...
- Lynozyfic Lynozyfic (linvoseltamab-gcpt) is a bispecific B-cell maturation antigen (BCMA)‑directed CD3 T-cell engager for the treatment of relapsed o...
- Zegfrovy Zegfrovy (sunvozertinib) is an oral, irreversible, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for the...